Nivolumab shows continued survival benefit in high-risk MIUC

Press/Media

Period	18 Feb 2023

Media coverage

Title	Nivolumab shows continued survival benefit in high-risk MIUC
Media name/outlet	Urology Times
Country/Territory	United States
Date	18/02/23
URL	ct.moreover.com/?a=50044695034&p=1gw&v=1&x=Rp_fMw7luKiRp9W2LXO-7A
Persons	Matthew Galsky

Title	Nivolumab Displays Sustained Survival Benefits in Urothelial Carcinoma
Media name/outlet	OncLive
Country/Territory	United States
Date	18/02/23
URL	ct.moreover.com/?a=50044844886&p=1gw&v=1&x=-X8HUotekWTyCAFT1g-Bnw
Persons	Matthew Galsky